Drugs / Timebutine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT01507922 Comparator | Dec 2011 → Mar 2013 | irritable bowel syndrome | Bukwang Pharmaceutical | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Timebutine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01507922 ↗ |
| Known as | Timebutine maleate | “Timebutine maleate 150mg three times a day for 8 weeks” NCT01507922 ↗ |